Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Monoclonal antibody DF3 correlates with tumor differentiation and hormone receptor status in breast cancer patients.

Lundy J, Thor A, Maenza R, Schlom J, Forouhar F, Testa M, Kufe D. Monoclonal antibody DF3 correlates with tumor differentiation and hormone receptor status in breast cancer patients. Breast Cancer Res Treat. 1985; 5(3):269-76.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.